^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Merkel Cell Carcinoma

Related cancers:
3d
Mouse model of Merkel cell carcinoma derived from the hair follicle. (PubMed, J Invest Dermatol)
Importantly, while sT-Ag alone induces partial MCC-associated gene expression, suppression of p53 is required for sT-Ag to induce neuroendocrine lineage transdifferentiation in the hair follicle. Cumulatively, these studies enhance our knowledge of MCC biology and establish a de novo MCC tumorigenesis model in a tractable immunocompetent system that will be invaluable for further advancements in the field.
Preclinical • Journal
|
TP53 (Tumor protein P53) • SOX9 (SRY-Box Transcription Factor 9)
3d
ADAM: Adjuvant Avelumab in Merkel Cell Cancer (clinicaltrials.gov)
P3, N=101, Active, not recruiting, University of Washington | Trial primary completion date: Apr 2026 --> Jan 2029
Trial primary completion date
|
Bavencio (avelumab)
6d
SUMMERTIME: SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines (clinicaltrials.gov)
P=N/A, N=35, Active, not recruiting, University Hospital, Tours | Not yet recruiting --> Active, not recruiting | N=150 --> 35 | Trial completion date: Sep 2023 --> Dec 2026 | Trial primary completion date: Sep 2021 --> Dec 2025
Enrollment closed • Enrollment change • Trial completion date • Trial primary completion date
15d
CXorf67 in malignancies: Deciphering epigenetic landscapes and clinical implications for precision oncology. (PubMed, Genes Dis)
However, further research is needed to explore its functions in other cancers and clarify its molecular mechanisms. Our review synthesizes current knowledge on CXorf67's biological significance, particularly in epigenetics and DNA damage, and its implications in oncogenesis.
Review • Journal
|
BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • PALB2 (Partner and localizer of BRCA2) • SUZ12 (SUZ12 Polycomb Repressive Complex 2 Subunit)
18d
Coexistence of Hyalinizing Trabecular Tumor and Papillary Thyroid Carcinoma: A Diagnostic Challenge. (PubMed, AACE Endocrinol Diabetes)
This case underscores the importance of integrating cytologic, histopathologic, and molecular features when evaluating thyroid nodules with overlapping characteristics. Recognition of this rare coexistence prevents misclassification and unnecessary aggressive management, ensuring accurate diagnosis and optimal patient outcomes.
Journal
|
NCAM1 (Neural cell adhesion molecule 1) • KRT19 (Keratin 19)
19d
Degradation-Controlled Synchronization of HIF-2α and MEK Inhibition Using Self-Sealed Porous Silicon Nanoparticles to Reprogram Tumor Immunogenicity. (PubMed, Acta Biomater)
In contrast, degradation-governed release from PSiNPs sustained the availability of belzutifan and trametinib in aqueous physiological medium for more than 10 days supporting prolonged intracellular drug exposure when combined with the established cellular internalization of this carrier system. Sustained dual inhibition enhanced cytotoxicity and promoted immunogenic remodeling in MCPyV-negative Merkel cell carcinoma models, including increased calreticulin exposure and reduced PD-L1 expression. These findings identify release synchronization as a critical biomaterial design parameter for combination cancer therapy.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • EPAS1 (Endothelial PAS domain protein 1) • CALR (Calreticulin)
|
PD-L1 expression
|
Mekinist (trametinib) • Welireg (belzutifan)
20d
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers (clinicaltrials.gov)
P=N/A, N=20, Active, not recruiting, University of Wisconsin, Madison | Recruiting --> Active, not recruiting
Enrollment closed
22d
Merkel Cell Polyomavirus and DNA Damage Response (DDR): Transcriptional Analysis of DDR Pathways in the Context of Merkel Cell Carcinoma. (PubMed, Cancers (Basel))
Our findings support the role of MCPyV in MCC formation and suggest its involvement in the transcriptional regulation of DDR genes, which may influence tumor progression. Understanding the molecular interplay between MCPyV and the DDR may guide future research into plausible novel diagnostic and therapeutic strategies for virus-induced tumors.
Journal
|
CHEK2 (Checkpoint kinase 2) • RAD51 (RAD51 Homolog A) • CHEK1 (Checkpoint kinase 1) • CDKN1A (Cyclin-dependent kinase inhibitor 1A)
23d
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma (clinicaltrials.gov)
P1, N=36, Recruiting, H. Lee Moffitt Cancer Center and Research Institute | Active, not recruiting --> Recruiting
Enrollment open
|
CD4 (CD4 Molecule)
|
Libtayo (cemiplimab-rwlc)
24d
Vulvar small cell neuroendocrine carcinoma arising from differentiated vulvar intraepithelial neoplasia: evidence of a clonal relationship by mutation analysis. (PubMed, Virchows Arch)
HPV testing was negative. These findings support the hypothesis of stepwise tumor progression from a squamous precursor with RB1 and TP53 alterations, suggesting a mechanism for neuroendocrine transdifferentiation.
Journal
|
TP53 (Tumor protein P53) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • RB1 (RB Transcriptional Corepressor 1)
|
TP53 mutation
27d
CARADERM: French National Database of Rare Dermatological Cancers (clinicaltrials.gov)
P=N/A, N=9000, Recruiting, University Hospital, Lille | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Dec 2026
Trial completion date • Trial primary completion date
1m
Role of POU4F3 in the Diagnosis of Cutaneous Follicular Tumors. (PubMed, J Cutan Pathol)
These findings support POU4F3's diagnostic value in distinguishing benign follicular tumors from malignant histopathologic mimics.
Journal
|
KRT20 (Keratin 20) • POU4F3 (POU Class 4 Homeobox 3)